48:52

L'élimination du SARM1 peut-elle constituer une thérapie pour les patients atteints de CMT2A ?

1:13:23

CMT1A Clinical Trial and Drug Development Update

1:09:20

OHio, What a Night: Lighting a Path to a Cure for Charcot-Marie-Tooth Disease

24:42

Next-Generation Strategies for Next-Generation Schwann Cell Targeting Therapeutics

25:11

ToPIC: Building a CMT Guidance Document for the FDA